Mutual fund investment has become an appealing opportunity for wealth accumulation. A key advantage of this investment avenue is its accessibility, as individuals can start investing with amounts as low as Rs 100 or Rs 200 through Systematic Investment Plans (SIPs). The power of compound interest, given time to grow, has the potential to turn … Read more
MUMBAI – The National Stock Exchange (NSE) of India will launch four new indices in the cash and futures and options segments with effect from April 8. The exchange has proposed online dissemination of indices namely, Nifty Tata Group 25% Cap, Nifty500 Multicap India Manufacturing 50:30:20, Nifty500 Multicap Infrastructure 50:30:20, and Nifty MidSmall Healthcare, according … Read more
Veteran fund manager Rajiv Jain said his GQG Partners LLC holds about $13 billion in India stocks and plans to buy more, downplaying corporate governance and political risks associated with his headline-generating investments in billionaire Gautam Adani’s beleaguered conglomerate. GQG holds positions in companies, including cigarette and hotel group ITC , the country’s biggest drugmaker … Read more
As per the agreement, the pharma majors will jointly sponsor, supervise and monitor the clinical trial in India. Five major pharma companies of India have entered into a collaboration for the clinical trial of oral anti-viral drug Molnupiravir for the treatment of mild COVID-19. Indian pharmaceutical companies that have joined hands for this are – … Read more
Mumbai: Most brokerages have retained a bullish view on despite the company’s March quarter profit missing estimates. Sun Pharmaceutical reported a 123% year-on-year rise in its consolidated net profit for the quarter ended March to ₹894.2 crore. CLSA, HSBC, and Motilal Oswal maintained buy, while Kotak Institutional and IIFL maintained add rating. Jefferies retained underperform. … Read more